Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041741 | SCV000065437 | benign | not specified | 2011-12-16 | criteria provided, single submitter | clinical testing | Arg4468Arg in exon 63 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (23/3738) of chromosomes from a broad African American population (dbSNP rs146994147). |
Gene |
RCV000041741 | SCV000727790 | likely benign | not specified | 2018-02-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041741 | SCV000862267 | likely benign | not specified | 2018-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000908912 | SCV001053696 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450774 | SCV004183178 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001831700 | SCV004183179 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001831700 | SCV002088265 | likely benign | Usher syndrome type 2A | 2019-12-14 | no assertion criteria provided | clinical testing |